Global Pneumonia Testing Market to reach a market size of $1.8 billion by 2024 - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Global Pneumonia Testing Market, published by KBV research, The Global Pneumonia Testing Market size is expected to reach $1.8 billion by 2024, rising at a market growth of 9.2% CAGR during the forecast period.

The North America market would dominate the Global Pneumonia Testing Diagnostic Centers Market by Region 2024; growing at a CAGR of 7.4 % during the forecast period. The Europe market is expected to witness a CAGR of 7.9% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 9.5% during (2018 - 2024).

The Analyzers market dominated the Global Pneumonia Testing Market by Type 2017, thereby, achieving a market value of $1,214.6 million by 2024. The Consumables market is expected to witness a CAGR of 9.9% during (2018 - 2024).

The Point-Of-Care (POC) Testing market dominated the Global Pneumonia Testing Market by Method 2017, growing at a CAGR of 8.6 % during the forecast period. The Immunodiagnostics market is expected to witness a CAGR of 9.3% during (2018 - 2024). Additionally, The Molecular Diagnostics market is expected to witness highest CAGR of 10.5% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/pneumonia-testing-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.

Global Pneumonia Testing Market Segmentation

By Method

  • Point-Of-Care (POC) Testing
  • Immunodiagnostics
  • Molecular Diagnostics

By End User

  • Diagnostic Centers
  • Hospitals
  • Homecare
  • Others

By Type

  • Analyzers
  • Consumables

By Technology

  • Enzyme-Linked Immuno sorbent Assay (ELISA)
  • Immunofluorescence
  • Western Blot,
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • Other Technology.

 By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BioMérieux
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Meridian Bioscience Inc.
  • Quest Diagnostics Incorporated
  • Quidel Corporation

Thermo Fisher Scientific

Unique Offerings from KBV Research

  • Exhaustive coverage  
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Pneumonia Testing Market

Europe Pneumonia Testing Market

Asia Pacific Pneumonia Testing Market

LAMEA Pneumonia Testing Market

 

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.